DE60210058T2 - Alkoxycarbonylamino-heteroaryl-carbonsäurederivate als ip-antagonisten - Google Patents

Alkoxycarbonylamino-heteroaryl-carbonsäurederivate als ip-antagonisten Download PDF

Info

Publication number
DE60210058T2
DE60210058T2 DE60210058T DE60210058T DE60210058T2 DE 60210058 T2 DE60210058 T2 DE 60210058T2 DE 60210058 T DE60210058 T DE 60210058T DE 60210058 T DE60210058 T DE 60210058T DE 60210058 T2 DE60210058 T2 DE 60210058T2
Authority
DE
Germany
Prior art keywords
compound
formula
radical
phenyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60210058T
Other languages
German (de)
English (en)
Other versions
DE60210058D1 (de
Inventor
Javier Francisco Union City LOPEZ-TAPIA
Dov San Jose NITZAN
Counde Sunnyvale O'Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE60210058D1 publication Critical patent/DE60210058D1/de
Publication of DE60210058T2 publication Critical patent/DE60210058T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60210058T 2001-03-02 2002-02-25 Alkoxycarbonylamino-heteroaryl-carbonsäurederivate als ip-antagonisten Expired - Fee Related DE60210058T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27284901P 2001-03-02 2001-03-02
US272849P 2001-03-02
PCT/EP2002/001942 WO2002070514A1 (en) 2001-03-02 2002-02-25 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists

Publications (2)

Publication Number Publication Date
DE60210058D1 DE60210058D1 (de) 2006-05-11
DE60210058T2 true DE60210058T2 (de) 2006-11-09

Family

ID=23041569

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60210058T Expired - Fee Related DE60210058T2 (de) 2001-03-02 2002-02-25 Alkoxycarbonylamino-heteroaryl-carbonsäurederivate als ip-antagonisten

Country Status (14)

Country Link
US (1) US6569860B2 (https=)
EP (1) EP1368345B1 (https=)
JP (1) JP2004526721A (https=)
KR (1) KR100589990B1 (https=)
CN (1) CN1280289C (https=)
AR (1) AR033429A1 (https=)
AT (1) ATE321041T1 (https=)
BR (1) BR0207730A (https=)
CA (1) CA2438813C (https=)
DE (1) DE60210058T2 (https=)
ES (1) ES2260425T3 (https=)
MX (1) MXPA03007864A (https=)
WO (1) WO2002070514A1 (https=)
ZA (1) ZA200306283B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040054008A1 (en) 2002-09-13 2004-03-18 Tohru Araki Medicament for treatment of nocturia
EP1596858A1 (en) * 2003-02-14 2005-11-23 Medical Research Council Ip receptor antagonists for the treatment of pathological uterine conditions
US7262313B2 (en) * 2005-10-20 2007-08-28 Lg Chem, Ltd. Organic silane compound
KR100822142B1 (ko) * 2005-10-20 2008-04-14 주식회사 엘지화학 신규한 유기 실란 화합물
AR069650A1 (es) * 2007-12-14 2010-02-10 Actelion Pharmaceuticals Ltd Derivados de aminopirazol como agonistas no peptidicos del receptor alx humano
US9321745B2 (en) * 2013-03-12 2016-04-26 Allergan, Inc. Inhibition of neovascularization by inhibition of prostanoid IP receptors
WO2014143591A1 (en) 2013-03-12 2014-09-18 Allergan, Inc. Inhibition of neovascularization by simultaneous inhibition of prostanoid ip and ep4 receptors
BR112020018094A2 (pt) 2018-03-08 2020-12-22 Incyte Corporation Compostos de aminopirazina diol como inibidores de pi3k-¿
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
EP4119138A1 (en) * 2021-07-12 2023-01-18 Universität Hamburg Dhodh inhibitors and their use as antiviral agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908842A (en) 1995-12-08 1999-06-01 Merck & Co., Inc. Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
US6184242B1 (en) 1997-09-04 2001-02-06 Syntex Usa (Llc) 2-(substituted-phenyl)amino-imidazoline derivatives
WO1999026925A1 (en) * 1997-11-26 1999-06-03 Yoshitomi Pharmaceutical Industries, Ltd. Tryptase inhibitors comprising heterocyclic amide compounds
RU2235095C2 (ru) * 1998-10-06 2004-08-27 Дайниппон Фармасьютикал Ко., Лтд. 2,3-дизамещенное производное пиридина, способы его получения, содержащая его фармацевтическая композиция и промежуточный продукт для его получения
US6335459B1 (en) * 1998-12-23 2002-01-01 Syntex (U.S.A.) Llc Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulators
WO2001012189A1 (en) * 1999-08-12 2001-02-22 Pharmacia Italia S.P.A. 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
KR100523119B1 (ko) * 2000-03-16 2005-10-20 에프. 호프만-라 로슈 아게 Ｉｐ 길항제로서의 카복실산 유도체

Also Published As

Publication number Publication date
WO2002070514A1 (en) 2002-09-12
KR20030078962A (ko) 2003-10-08
CA2438813A1 (en) 2002-09-12
ZA200306283B (en) 2004-11-15
MXPA03007864A (es) 2003-12-04
DE60210058D1 (de) 2006-05-11
US20020169171A1 (en) 2002-11-14
US6569860B2 (en) 2003-05-27
CN1280289C (zh) 2006-10-18
CA2438813C (en) 2008-07-29
ATE321041T1 (de) 2006-04-15
AR033429A1 (es) 2003-12-17
CN1494544A (zh) 2004-05-05
ES2260425T3 (es) 2006-11-01
JP2004526721A (ja) 2004-09-02
KR100589990B1 (ko) 2006-06-15
EP1368345B1 (en) 2006-03-22
EP1368345A1 (en) 2003-12-10
BR0207730A (pt) 2004-03-23

Similar Documents

Publication Publication Date Title
DE60113563T2 (de) Substituierte 2-phenylaminoimidazolin-phenyl-ketonderivate als ip-antagonisten
DE60308670T2 (de) Substituierte indole als alpha-1 agonisten
DE69838829T2 (de) N-Phenylalkylsulfonamid-Derivate, deren Herstellung und deren Verwendung als a lpha-1A/1L-Adrenozeptoragonisten
AU777961B2 (en) Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds
DE60106607T2 (de) Substituierte 1-aminoalkyl-lactame und ihre verwendung als muscarinrezeptor antagonisten
DE60005485T2 (de) Indolderivate und ihre verwendung als mcp-1 rezeptor antagonisten
DE60017115T2 (de) Amid-derivate und deren medizinische verwendung
EP0497852A1 (de) Bicyclo-imidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DE19955794A1 (de) Pyrrolidin-Derivate-CCR-3-Rezeptor-Antagonisten
DE602005005456T2 (de) Neue azabicyclische derivate, herstellungsverfahren dafür und sie enthaltende pharmazeutische zusammensetzungen
CN106800537B (zh) 丁苯酞-替米沙坦杂合物及其制备方法和用途
DE3426419A1 (de) Neue oxindol-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte
DE60210058T2 (de) Alkoxycarbonylamino-heteroaryl-carbonsäurederivate als ip-antagonisten
BE898278A (fr) Benzoxazines antipsychotiques.
DE60313769T2 (de) 3-(pyridinyl-amino)-1h-indol-2-carbonsäure-verbindungen als inhibitoren der interleukin-4 genexpression
LU86049A1 (de) Aethylendiaminmonoamid-derivate
DE60207399T2 (de) Alkoxycarbonylaminobenzoesäure- oder alkoxycarbonylaminotetrazolylphenylderivate als ip-antagonisten
JP3046076B2 (ja) 腸運動性ベンズアミド
DE69612753T2 (de) (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridincarboxamid, verfahren zu seinerherstellung und dieses enthaltende medizinische zubereitung
EP0739892A2 (de) Chromon-Derivate
DE60216279T2 (de) Alkyliden- pirazolidindion derivate und deren verwendung gegen diabetes und obesitas
KR20060008951A (ko) Ｉｐ 길항제로서 이미다졸린-2-일아미노페닐 아마이드
KR20010031839A (ko) 한 개의 질소원자를 함유하는 5, 6 또는 7원헤테로사이클릭 환으로 치환된 이미다조일알킬
JP2012510496A (ja) １−（４−（ピリジン−２−イル）ベンジル）イミダゾリジン−２，４−ジオン誘導体
KR100437561B1 (ko) 신규헤테로고리화합물

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee